company background image
AMRS

Amyris NasdaqGS:AMRS Stock Report

Last Price

US$1.74

Market Cap

US$566.5m

7D

-3.3%

1Y

-71.8%

Updated

08 Dec, 2022

Data

Company Financials +
AMRS fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health0/6
Dividends0/6

AMRS Stock Overview

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America.

Amyris, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Amyris
Historical stock prices
Current Share PriceUS$1.74
52 Week HighUS$6.79
52 Week LowUS$1.44
Beta1.08
1 Month Change-32.82%
3 Month Change-53.72%
1 Year Change-71.75%
3 Year Change-50.22%
5 Year Change-50.14%
Change since IPO-99.30%

Recent News & Updates

Recent updates

At US$2.95, Is Amyris, Inc. (NASDAQ:AMRS) Worth Looking At Closely?

Oct 31
At US$2.95, Is Amyris, Inc. (NASDAQ:AMRS) Worth Looking At Closely?

Are Investors Undervaluing Amyris, Inc. (NASDAQ:AMRS) By 43%?

Sep 02
Are Investors Undervaluing Amyris, Inc. (NASDAQ:AMRS) By 43%?

Amyris, Inc. (NASDAQ:AMRS) Just Reported, And Analysts Assigned A US$10.91 Price Target

Aug 12
Amyris, Inc. (NASDAQ:AMRS) Just Reported, And Analysts Assigned A US$10.91 Price Target

Shareholder Returns

AMRSUS ChemicalsUS Market
7D-3.3%-1.7%-2.8%
1Y-71.8%-8.3%-19.6%

Return vs Industry: AMRS underperformed the US Chemicals industry which returned -9.2% over the past year.

Return vs Market: AMRS underperformed the US Market which returned -21.2% over the past year.

Price Volatility

Is AMRS's price volatile compared to industry and market?
AMRS volatility
AMRS Average Weekly Movement19.7%
Chemicals Industry Average Movement6.8%
Market Average Movement7.4%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.3%

Stable Share Price: AMRS is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 20% a week.

Volatility Over Time: AMRS's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2003980John Melohttps://amyris.com

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names.

Amyris, Inc. Fundamentals Summary

How do Amyris's earnings and revenue compare to its market cap?
AMRS fundamental statistics
Market CapUS$566.50m
Earnings (TTM)-US$341.15m
Revenue (TTM)US$258.82m

2.2x

P/S Ratio

-1.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AMRS income statement (TTM)
RevenueUS$258.82m
Cost of RevenueUS$337.01m
Gross Profit-US$78.19m
Other ExpensesUS$262.96m
Earnings-US$341.15m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.05
Gross Margin-30.21%
Net Profit Margin-131.81%
Debt/Equity Ratio-198.6%

How did AMRS perform over the long term?

See historical performance and comparison